You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

CORPORATE

Kedrion Biopharma supports the launch of "Nature Italy"

The Company reaffirms and strengthens its commitment to research and innovation

read more 

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

EVENTS

Kedrion supports the 2020 European Hemophilia Consortium Conference

The company renews its commitment alongside the EHC, which continues to support the PARTNERS project

read more 

  1. CORPORATE - 04-10-2019

    Kedrion submits to FDA for Manufacture of RhoGAM/MICRhoGAM in Melville, NY

    read more 

  2. EVENTS - 30-09-2019

    Kedrion reaffirms its commitment for the global eradication of Rh disease

    A worldwide initiative for maternal and fetal health launches in Florence, Italy

    read more 

  3. EVENTS - 17-07-2019

    Leading medical-scientific event on Hemophilia held in Trieste, Italy

    Kedrion-organized congress put replacement therapy, personalization and access to care in the spotlight

    read more 

  4. EVENTS - 05-07-2019

    Kedrion scientific symposium at the 2019 PNS Conference in Genoa, Italy

    A chance for world Key Opinion Leaders to debate possible new therapies for the treatment of CIPN

    read more 

Pages

For more information please contact: pressoffice@kedrion.com